Thoracic Imaging

What Is the Best Initial Imaging for Chronic Dyspnea After a COVID-19 Infection?

·
What Is the Best Initial Imaging for Chronic Dyspnea After a COVID-19 Infection?

A 45-year-old patient is in your primary care clinic, six months after a confirmed but “mild” case of COVID-19. They report a persistent, nagging shortness of breath on exertion that hasn’t improved. Their oxygen saturation is normal at rest, and the physical exam is unremarkable. You’ve ruled out a cardiac cause. Now, you need to evaluate for pulmonary sequelae. What is the most appropriate first imaging study to order? This article details the American College of Radiology (ACR) workflow for this specific scenario. For the initial imaging of an adult with chronic dyspnea and a history of COVID-19, a chest radiograph is rated Usually Appropriate.

Who Fits This Clinical Scenario for Post-COVID-19 Dyspnea?

This workflow is for adults presenting with chronic dyspnea, defined as shortness of breath lasting more than four weeks. The key distinguishing feature is a known or strongly suspected prior infection with SARS-CoV-2. The patient’s symptoms have persisted well beyond the acute phase of the illness, prompting an evaluation for long-term pulmonary complications. This evaluation is for the initial imaging step in the outpatient or primary care setting.

This guidance is distinct from other chronic dyspnea scenarios. It does not apply if:

  • The etiology is completely unclear: If there is no history of COVID-19 or other clear precipitating illness, the workup follows a broader pathway for chronic dyspnea of unclear etiology.
  • Chronic Obstructive Pulmonary Disease (COPD) is the primary suspicion: If the patient has a significant smoking history and clinical findings suggestive of COPD, the imaging workup is tailored to that specific diagnosis.
  • Small airways disease is suspected without a COVID-19 link: While post-COVID-19 symptoms can involve small airways, this specific scenario focuses on the broader initial workup after the infection, not a primary suspicion of isolated small airways disease from other causes.

The focus here is on identifying potential structural lung changes that have developed as a sequela of a prior COVID-19 infection, guiding further management and potential referral to a pulmonologist.

What Diagnoses Are You Working Up in This Scenario?

When a patient presents with chronic dyspnea after COVID-19, the differential diagnosis centers on the known pulmonary sequelae of the infection. The goal of initial imaging is to detect or rule out significant structural changes that could explain the persistent symptoms.

Post-COVID-19 Interstitial Lung Disease (ILD) and Fibrosis: This is a primary concern. Severe COVID-19 can lead to acute respiratory distress syndrome (ARDS), which can heal with fibrosis. Even in less severe cases, a persistent inflammatory response can result in fibrotic lung changes, causing restrictive physiology and dyspnea. Imaging seeks to identify signs like reticulation, traction bronchiectasis, and honeycombing.

Organizing Pneumonia (OP): A common non-resolving pattern following viral pneumonia, OP involves inflammation and plugs of granulation tissue in the small airways and alveoli. While it can resolve, sometimes with corticosteroids, it can also persist and contribute to chronic symptoms. Imaging may show patchy ground-glass opacities or consolidations, often in a peripheral or peribronchovascular distribution.

Bronchiectasis or Bronchiolectasis: Damage to the airway walls during the acute infection can lead to permanent dilation of the bronchi or bronchioles. This can impair mucus clearance, predispose to recurrent infections, and cause chronic cough and dyspnea. Imaging can reveal bronchial wall thickening and luminal dilation.

Exclusion of Other Causes: It is also crucial to ensure that the dyspnea is not from an unrelated, superimposed process. Initial imaging helps screen for other common causes of dyspnea, such as a new pleural effusion, cardiomegaly suggesting a developing heart failure, or an unexpected mass.

Why Is a Chest Radiograph the Recommended Initial Study?

For an adult with chronic dyspnea following a known or suspected COVID-19 infection, the American College of Radiology designates a Radiography chest as Usually Appropriate. This recommendation is based on a balance of diagnostic utility, accessibility, and safety for an initial evaluation.

A standard two-view chest radiograph serves as an excellent first-line screening tool. It is highly effective at detecting significant parenchymal abnormalities like extensive fibrosis, large areas of consolidation consistent with organizing pneumonia, or significant pleural disease. It provides a global assessment of the lungs, heart, and mediastinum, helping to rule out many alternative causes of dyspnea. Its extremely low radiation dose (☢ <0.1 mSv) and wide availability make it the ideal starting point.

While a CT chest without IV contrast is also rated as Usually Appropriate, it is generally considered a second-line or problem-solving tool in this context. A CT, particularly a high-resolution CT (HRCT), is far more sensitive for subtle interstitial changes, early fibrosis, and small airways disease. However, it involves a significantly higher radiation dose (☢☢☢ 1-10 mSv) and is less accessible. The logical workflow is to start with the radiograph and proceed to CT if the radiograph is abnormal, or if it is normal but symptoms are severe and unexplained.

Other imaging modalities are rated lower for this initial workup:

  • CT chest with IV contrast is Usually Not Appropriate as the initial test unless there is a specific clinical suspicion for chronic pulmonary embolism or another vascular abnormality. The contrast adds risk (allergic reaction, nephrotoxicity) without benefiting the primary evaluation for parenchymal lung disease.
  • MRI chest is Usually Not Appropriate because it provides poor spatial resolution of the lung parenchyma and is susceptible to motion artifact, making it unsuitable for evaluating interstitial lung disease or fibrosis.

The principle is to use the simplest, safest test first. The chest radiograph effectively triages patients, identifying those with clear abnormalities who need further characterization with CT, while avoiding unnecessary radiation in those with normal findings.

What’s Next After a Chest Radiograph? Downstream Workflow

The results of the initial chest radiograph will guide the subsequent clinical pathway. The decision tree branches based on whether the findings are positive, negative, or indeterminate, always in the context of the patient’s clinical status.

If the chest radiograph is positive: If the radiograph shows clear abnormalities such as reticulation, persistent opacities, or signs of volume loss, the next step is typically a CT chest without IV contrast (specifically, a high-resolution protocol). The CT will precisely characterize the pattern and extent of disease (e.g., fibrosis vs. organizing pneumonia), which is critical for prognosis and treatment planning. This should be paired with pulmonary function tests (PFTs) to assess functional impairment and a referral to a pulmonologist.

If the chest radiograph is negative: A normal radiograph is reassuring but does not definitively exclude underlying lung disease, especially mild interstitial changes or small airways disease. If the patient’s dyspnea is mild and improving, a course of observation may be reasonable. However, if symptoms are significant, persistent, or worsening despite the normal radiograph, the workup should proceed to PFTs. If PFTs show a restrictive or gas exchange abnormality, or if clinical suspicion remains high, a non-contrast chest CT is warranted to look for disease not visible on the plain film.

If the chest radiograph is indeterminate: Findings such as subtle basal opacities or questionable interstitial prominence are common. In these cases, a non-contrast chest CT is the definitive next step to clarify the ambiguity and determine if clinically significant pathology is present.

Pitfalls to Avoid (and When to Get Help)

When working up chronic dyspnea after COVID-19, several common pitfalls can lead to diagnostic delays or misinterpretation. Be mindful of the following:

  • Over-reliance on a normal radiograph: A normal chest X-ray does not rule out early or mild interstitial lung disease. If a patient has significant exertional desaturation or concerning PFT results, do not stop the workup based on a normal film.
  • Prematurely ordering CT with contrast: Unless there is a specific reason to suspect chronic thromboembolic disease (e.g., prior DVT/PE, signs of right heart strain), the default CT should be a non-contrast, high-resolution study to maximize parenchymal detail and minimize radiation and contrast risks.
  • Anchoring on the COVID-19 diagnosis: While post-COVID sequelae are common, the patient’s dyspnea could be from a new, unrelated condition. Always consider the broad differential for dyspnea, including cardiac causes, anemia, or a new malignancy.

If the clinical picture and imaging findings are complex, or if the patient shows progressive decline, escalation to a pulmonologist for a comprehensive evaluation, including potential bronchoscopy, is the appropriate next step.

Related ACR Topics and Tools

This article covers one specific scenario within the broader topic of non-cardiovascular chronic dyspnea. For a comprehensive overview and to compare this workflow with others, please consult the resources below.

Frequently Asked Questions

Why not start with a CT scan for post-COVID dyspnea, since it’s more sensitive?

While a CT scan is more sensitive for subtle lung disease, a chest radiograph is the recommended initial test because it provides a good balance of diagnostic information with a much lower radiation dose and greater accessibility. It effectively screens for significant abnormalities, and a CT can be reserved for patients with a positive radiograph or those with severe symptoms despite a normal one, following a stepwise diagnostic approach.

Is there a role for CT with contrast (CTA) in this scenario?

A CT with intravenous contrast (specifically, a CT angiogram or CTA) is rated ‘Usually Not Appropriate’ for the *initial* imaging of post-COVID dyspnea unless there is a specific clinical suspicion of chronic thromboembolic pulmonary hypertension (CTEPH). For evaluating lung parenchyma for fibrosis or organizing pneumonia, non-contrast high-resolution CT is superior and avoids the risks associated with IV contrast.

What if the chest radiograph is normal but the patient is still very symptomatic?

A normal chest radiograph does not rule out post-COVID lung pathology. If a patient has persistent, significant dyspnea, exertional hypoxia, or other concerning symptoms, the next steps should include pulmonary function tests (PFTs) and consideration of a non-contrast high-resolution chest CT to look for subtle interstitial or small airways disease not visible on the radiograph.

How long after a COVID-19 infection should I wait before imaging for chronic dyspnea?

The term ‘chronic dyspnea’ is typically defined as symptoms lasting longer than four weeks. Most guidelines suggest waiting at least 12 weeks from the initial infection before embarking on a full workup for long-term sequelae, as many symptoms may resolve spontaneously within that timeframe. However, imaging may be pursued earlier if symptoms are severe, worsening, or accompanied by red flags like hypoxemia.

Does this guidance apply if the patient was asymptomatic during their COVID-19 infection?

Yes, this guidance applies regardless of the severity of the initial COVID-19 infection. Post-COVID pulmonary complications, including interstitial lung changes, have been reported even in patients who had mild or asymptomatic acute infections. The presence of new, persistent chronic dyspnea is the primary trigger for this imaging workflow.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026